{"count": 2, "results": [{"_id": "1418836", "pmid": 1418836, "title": "A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.", "journal": "Am J Hypertens", "authors": ["Johnson BF", "Frishman WH", "Brobyn R", "Brown RD", "Reeves RL", "Wombolt DG"], "date": "1992-10-01T00:00:00Z", "doi": "10.1093/ajh/5.10.727", "meta_date_publication": "1992 Oct", "meta_volume": "5", "meta_issue": "10", "meta_pages": "727-32", "score": 50048.66, "text_hl": "Heart rate was significantly lowered by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ only. Both @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ were well-tolerated. ", "citations": {"NLM": "Johnson BF, Frishman WH, Brobyn R, Brown RD, Reeves RL, Wombolt DG. A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension. Am J Hypertens. 1992 Oct;5(10):727-32. PMID: 1418836", "BibTeX": "@article{1418836, title={A randomized, placebo-controlled, double-blind comparison of amlodipine and atenolol in patients with essential hypertension.}, author={Johnson BF and Frishman WH and Brobyn R and Brown RD and Reeves RL and Wombolt DG}, journal={Am J Hypertens}, volume={5}, number={10}, pages={727-32}}"}}, {"_id": "23521647", "pmid": 23521647, "title": "Mechanisms underlying transient receptor potential ankyrin 1 (TRPA1)-mediated hyperalgesia and edema.", "journal": "J Peripher Nerv Syst", "authors": ["Perin-Martins A", "Teixeira JM", "Tambeli CH", "Parada CA", "Fischer L"], "date": "2013-03-01T00:00:00Z", "doi": "10.1111/jns5.12010", "meta_date_publication": "2013 Mar", "meta_volume": "18", "meta_issue": "1", "meta_pages": "62-74", "score": 50046.113, "text_hl": "Finally, a cyclooxygenase inhibitor (@CHEMICAL_Indomethacin @CHEMICAL_MESH:D007213 @@@indomethacin@@@, 100 microg/paw), a @GENE_UGT1A1 @GENE_24861 @@@beta1@@@ (@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, 6 microg/paw) or a @GENE_UGT1A2 @GENE_396527 @@@beta2@@@ (@CHEMICAL_ICI_118551 @CHEMICAL_MESH:C026777 @@@ICI 118, 551@@@, 1.5 microg/paw) adrenoceptor antagonist also significantly reduced @CHEMICAL_allyl_isothiocyanate @CHEMICAL_MESH:C004471 @@@AITC@@@-induced @DISEASE_Hyperalgesia @DISEASE_MESH:D006930 @@@hyperalgesia@@@ and @<m>DISEASE_Edema</m> @DISEASE_MESH:D004487 @@@edema@@@. ", "citations": {"NLM": "Perin-Martins A, Teixeira JM, Tambeli CH, Parada CA, Fischer L. Mechanisms underlying transient receptor potential ankyrin 1 (TRPA1)-mediated hyperalgesia and edema. J Peripher Nerv Syst. 2013 Mar;18(1):62-74. PMID: 23521647", "BibTeX": "@article{23521647, title={Mechanisms underlying transient receptor potential ankyrin 1 (TRPA1)-mediated hyperalgesia and edema.}, author={Perin-Martins A and Teixeira JM and Tambeli CH and Parada CA and Fischer L}, journal={J Peripher Nerv Syst}, volume={18}, number={1}, pages={62-74}}"}}]}